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Cyclosporine A induces apoptosis in murine tubular epithelial
cells: Role of caspases.
Background. The pathogenesis of cyclosporine A (CsA) neph-
rotoxicity has not been completely elucidated.
Methods. The ability of CsA to induce apoptosis in cultured
murine tubular epithelial cells and its regulation by the cell
microenvironment and inhibitors of caspases were studied.
Results. This study found that CsA induces apoptotic death in
murine proximal tubular epithelial MCT cells in a dose- (0.1 to 15
mg/ml) and time-dependent (24 to 72 hr) manner. Death caused
by CsA is additive to apoptosis induced by deprivation of the
survival factors present in serum. Primary cultures of murine
tubular epithelial cells are also sensitive to CsA-induced apopto-
sis. Peptide inhibitors of caspases such as zVAD-fmk (which
inhibits caspases 8 and 9) and DEVD-CHO (which inhibits
caspase 3 and related caspases) prevented CsA-induced apoptosis
in MCT cells, although zVAD-fmk was effective at lower concen-
trations.
Conclusion. These data suggest that tubular cell apoptosis
mediated by caspases may play a role in CsA nephrotoxicity and
that the microenvironment modulates resistance to CsA lethality
as low local levels of survival factors may potentiate nephrotoxic-
ity. Caspases my be new therapeutic targets in the management of
nephrotoxic injury.
Nephrotoxicity is the main adverse effect of cyclosporine
A (CsA). CsA causes acute renal damage as well as a
chronic tubulointerstitial nephropathy characterized by tu-
bular atrophy, loss of tubular cells and interstitial fibrosis
[reviewed in 1, 2]. The mechanisms of chronic CsA neph-
rotoxicity is unclear. It has been suggested that the tubulo-
interstitial damage is a consequence of chronic renal isch-
emia [1, 2]. However, there is also evidence for a direct
tubular toxicity of CsA [3]. Although the mechanisms of
CsA tubulotoxicity have not been defined, an increased rate
of tubular cell apoptosis was observed in human renal
biopsy specimens obtained from patients with CsA neph-
rotoxicity [4]. Apoptosis is an active mode of cell death that
promotes cell loss during both acute and chronic renal
damage [5]. Apoptosis is characterized by morphological
changes (cell shrinkage, chromatin margination, and nu-
clear condensation and fragmentation), and activation of
an endogenous endonuclease yields a typical pattern of
internucleosomal DNA degradation. Most important of all,
apoptosis involves the activation of a highly conserved
intracellular death program that provides the opportunity
for therapeutic intervention [5]. The cysteine proteases
caspases are basic components of this program and inhibi-
tion of certain caspases may protect the cells from apopto-
sis [reviewed in 6]. However, the caspases that participate
in renal cell death have not been characterized. The death
program may be activated by the presence of extracellular
lethal factors or by the absence of so-called survival factors.
CsA induces apoptosis of lymphoid cells [7]. We have
studied the capacity of CsA to induce apoptosis in murine
renal tubular epithelial cells and the modulatory effect of
the cell microenvironment and of inhibitors of caspases.
METHODS
Cells
Murine proximal tubular epithelial (MCT) cells [8, 9]
were cultured in RPMI 1640 (GIBCO, Grand Island, NY,
USA), 10% decomplemented fetal calf serum (FCS), 2 mM
glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin,
in 5% CO2 at 37°C. CsA (Sandoz Pharma, Barcelona,
Spain) was dissolved in ethanol. Primary cultures of murine
proximal tubular epithelial cells (a kind gift from Carlos
Pen˜aranda, Fundacio´n Jime´nez Dı´az) were also tested for
their susceptibility to CsA-induced apoptosis.
Studies of cell death and apoptosis
For quantification of cell death and apoptosis 20000 cells
were seeded in 24-well plates (Costar, Cambridge, MA,
USA) in 10% FCS RPMI. CsA (0.01 to 15 mg/ml), or
vehicle (ethanol, final concentration 0.1%) were added to
cells grown in 10% FCS RPMI or to cells that had been
deprived of serum for 24 hours. The caspase inhibitory
peptides Acetyl-Asp-Glu-Val-Asp-aldehyde (DEVD-CHO)
and benzyloxycarbonyl-Val-Ala-DL-Asp-fluoromethylketone
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(zVAD-fmk) were obtained from Bachem (Bubendorf,
Switzerland) and used at concentrations previously shown
to protect from apoptosis in other cell systems [reviewed in
6]. DEVD-CHO was dissolved in water and zVAD-fmk in
DMSO. Final concentration of DMSO was 0.05% and it
did not influence MCT cell apoptosis. Both peptides or
vehicle were added to the cell cultures three hours prior to
addition of CsA. Cells were cultured in the presence of
stimuli for an additional 24 to 72 hours. Cells attached to
the plate were detached with trypsin/EDTA and mixed with
detached cells present in the supernatant. Cell survival was
determined in pooled cells by trypan blue exclusion. At
least 200 cells were counted in quadruplicate wells.
Apoptosis was characterized by morphologic and func-
tional criteria. Nuclei of formalin-fixed cells were stained
with propidium iodide in the presence of RNAse A to
observe the typical morphological changes, as previously
described [10, 11]. Cells exposed to CsA were also fixed in
glutaraldehyde/paraformaldehyde and processed for elec-
tron microscopy [12]. For assessment of apoptosis by flow
cytometry adherent cells were pooled with spontaneously
detached cells, and stained in 100 mg/ml propidium iodide,
0.05% NP-40, 10 mg/ml RNAse A in PBS and incubated at
4°C for more than one hour. The percentage of apoptotic
cells with decreased DNA staining (A0) was counted as
previously described [13]. The protection from apoptosis
offered by peptide inhibitors of caspases was expressed as a
percentage of specific apoptosis induced by CsA in the
presence of the peptide vehicle, which was considered to be
100%. Specific apoptosis induced by CsA was calculated by
subtracting apoptosis encountered in cells cultured in the
presence of the CsA vehicle, 0.1% ethanol. Internucleoso-
mal DNA fragmentation was investigated in genomic DNA
obtained from attached or detached cells that were lysed in
hypotonic lysis buffer [10]. DNA was separated in a 1.5%
agarose gel, and stained with ethidium bromide.
Statistics
Results are expressed as mean 6 SD. Significance at the
95% level was established using one-way ANOVA and
Bonferroni’s method by means of the SigmaStat statistical
software (Jandel, San Rafael, CA, USA).
Fig. 1. Cyclosporine A (CsA) induces apoptosis of tubular epithelial cells. (A) Cells grown in serum-free conditions were fixed in 10% formalin and
stained with propidium iodide. Tubular cells grown in 0.1% ethanol vehicle displayed pale, oval nuclei. Bright, condensed and fragmented nuclei
(apoptotic cells) were observed after treatment with 10 mg/ml CsA for 48 hours (CsA). The caspase inhibitory peptides 200 mM zVAD-fmk and 400 mM
DEVD-CHO protected from CsA-induced apoptosis. (B) Gel electrophoresis of DNA obtained from cells grown in the presence of 10% FCS
demonstrated the presence of internucleosomal DNA degradation in detached cells (detach) treated with 10 mg/ml CsA for 24 hours, which was absent
in cells treated with the ethanol vehicle (Et). The DNA of cells that remained attached (attach) to the plate was mostly intact, as assessed by its high
molecular weight. This is consistent with the low percentage (,5%) of cells with apoptotic morphology that remained attached to the plate, even after
treatment with CsA in the presence of 10% FCS. Abbreviation pGEM is molecular weight markers.
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RESULTS
CsA induces tubular cell death
CsA was toxic to cultured renal tubular epithelial cells. In
the presence of survival factors (10% FCS), trypan blue
exclusion detected a significant lethality in cells treated
with CsA for 24 hours (0.1% ethanol, 10.9 6 0.9%, 10
mg/ml CsA, 36.9 6 3.4% dead cells, P , 0.0001). However,
most cells were only lightly stained by trypan blue and had
decreased cell size. Only occasional dark blue cells with
increased size, consistent with primary necrosis, were ob-
served. A dose-response (0.1 to 15 mg/ml CsA) relationship
was observed (not shown). CsA-induced cell death in-
creased from 24 to 72 hours. Serum deprivation induced,
per se, tubular cell death. CsA toxicity was additive to that
induced by serum deprivation.
Death induced by CsA has features of apoptosis
The mechanism of CsA-induced cell death was assessed
by morphological and functional studies. Propidium iodide
staining revealed the characteristic bright, shrunk, frag-
mented nuclei of apoptosis among cells treated with CsA
(Fig. 1A). The percentage of apoptotic bodies was in-
creased among cells treated with CsA that remained at-
tached to the slide (at 24 hr, in 10% FCS, 0.1% ethanol
0.3 6 0.1%, 10 mg/ml CsA, 3.8 6 0.5% apoptotic cells, P ,
0.001). A higher percentage of apoptotic cells was found in
the pool of attached and detached cells, with values similar
to those obtained when hypodiploid cells were quantified in
pooled cells by flow cytometry. This indicates that, as
expected, most apoptotic cells detach from the culture
substrate. Electron microscopy confirmed that cells treated
with CsA display the apoptotic morphology (not shown)
[10, 13]. Functionally, the internucleosomal DNA degrada-
tion typical of apoptosis was present among detached,
CsA-treated cells (Fig. 1B). Flow cytometry analysis of cell
DNA content demonstrated a distinct peak of hypodiploid
(A0), apoptotic cells among CsA-treated cells (Fig. 2A).
The percentage of apoptotic cells was higher in the absence
(Fig. 3) than in the presence of serum, that was used as a
source of survival factors (in 10% FCS A0 cells at 24 hr,
0.1% ethanol 2.9%, 10 mg/ml CsA 25.7%). Apoptosis
induced by CsA was time-dependent, that is, it was already
noted in cells treated with 10 mg/ml CsA for 24 hours and
increased at later time points (Fig. 3A). At 24 hours there
was no evident increase in apoptosis with the lower con-
centrations of CsA (0.1 to 1 mg/ml), but at later time points
an increased rate of apoptosis was induced by $0.1 mg/ml
CsA and a dose-response relationship was observed (Fig.
3B). CsA (10 mg/ml) also induced apoptosis in primary
cultures of murine tubular epithelial cells (not shown).
Peptide inhibitors of caspases protect MCT cells from
CsA-induced apoptosis
Cells treated with 200 mM zVAD-fmk were protected
from CsA-induced apoptosis as assessed by morphology or
DNA content (Figs. 1A and 2). DEVD-CHO was also
protective, although it required higher concentrations
(Figs. 1A and 2). Neither peptide significantly inhibited
apoptosis induced by serum deprivation under the condi-
tions of the study.
DISCUSSION
This paper reports that CsA induces apoptosis in a
murine proximal tubular epithelial cell line and in primary
Fig. 2. Flow cytometry assessment of CsA-induced apoptosis: Prevention
by caspase inhibitors. (A) Flow cytometry showed that cells treated with
15 mg/ml CsA for 24 hours in the absence of serum displayed a distinct
peak of apoptotic cells with hypodiploid DNA content. This peak was
negligible in ethanol vehicle-treated cells or cells pretreated with the
caspase inhibitory peptides 200 mM zVAD-fmk and 400 mM DEVD-CHO.
(B) Caspase inhibitors protect from CsA-induced apoptosis. Protection
from apoptosis is expressed as a percentage of apoptosis induced by CsA,
which was considered to be 100%. Cells were incubated for 24 hours under
serum-free conditions in the presence of inhibitors and 15 mg/ml CsA and
apoptosis was quantified by flow cytometry. Mean 6 SD of three indepen-
dent experiments. *P , 0.005 versus CsA alone.
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cultures of murine tubular epithelial cells. CsA-induced
apoptosis was already noted at concentrations similar to
those found in the blood of patients treated with CsA (0.1
to 0.5 mg/ml), and it increased with dose and time. The
capacity of CsA to induce apoptosis of tubular cells may be
related to its nephrotoxicity. Even small increases in the
rate of apoptosis can result in a significant loss of cells in
vivo. The half life of a cell displaying the apoptotic mor-
phology has been calculated to be one to two hours. In the
developing central nervous system the presence of ,1% of
apoptotic cells in tissue sections results in the loss of more
than 50% of the cell mass after 72 hours [14]. Thus, small
rates of apoptotic death of tubular cells may lead, after
weeks or months, to the chronic tubular atrophy observed
in animals and patients receiving long-term CsA therapy [1,
2].
The pathways that lead to CsA-induced apoptosis are
unclear. The present study provides evidence that caspases
play a prominent role in CsA-induced apoptosis. zVAD-
fmk protected from CsA apoptosis. This effect may point to
a new target in the prevention and therapy of nephrotox-
icity, as zVAD-fmk has been successfully used to prevent
apoptosis in vivo [15]. ZVAD-fmk inhibits caspase-8
(MACH/FLICE/Mch5), an upstream effector of death
receptor mediated apoptosis [16]. This may suggest a role
for the autocrine activation of a death receptor system,
such as the Fas ligand-Fas system, in CsA-induced apopto-
sis. We have indeed observed that CsA increases the
expression of the Fas receptor in MCT cells (unpublished
observation), and these cells do express the Fas ligand [11].
Other drugs, such as chemotherapeutic agents, are known
to induce apoptosis through the activation of the Fas
ligand-Fas system [17]. The possibility that CsA-induced
apoptosis in tubular cells is mediated through this pathway
deserves further studies. There are other zVAD-fmk tar-
gets, such as caspase 9. Caspase 9 (Mch6/ICE-LAP6) is an
upstream caspase that binds to Apaf-1 and Apaf-2 (cyto-
chrome c), forming a complex that activates caspase 3 and
other caspases [18]. The main target of the inhibitory
peptide DEVD-CHO are caspase 3 (yama/apopain/CPP32)
and caspase 3-like enzymes [19]. Caspase-3 is implicated in
the final common pathway in several modes of apoptosis [6]
and is not inhibited by zVAD-fmk.
Another interesting finding of our study is that the rate of
apoptosis induced by CsA varies with the microenviron-
ment. CsA-induced cell death is decreased in the presence
of a cytokine microenvironment that favors cell survival,
that is, the presence of serum. The dependence of CsA-
induced lethality on the microenvironment may have direct
clinical consequences. Adverse conditions for cell survival
may be encountered during rejection or ischemic insult to
the kidney, in which the production of survival factors may
be decreased [20]. Our in vitro observations may be relevant
to the observed impaired recovery from post-transplant
acute renal failure in kidney graft recipients treated with
CsA.
In conclusion, our data suggest that apoptosis may play a
role in the loss of tubular cells in CsA nephrotoxicity, and
that the cell microenvironment may be important in deter-
mining the extent of CsA-induced tubular cell damage.
Several caspases, most probably caspases 8, 9 and 3, may be
involved in CsA-induced tubular cell apoptosis and are
potential targets for therapeutic intervention.
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Fig. 3. CsA induces apoptosis of murine proximal tubular epithelial cells (MCT) in a time- and dose-dependent manner. (A) Time-response curve of
apoptosis induced by 10 mg/ml CsA in serum-deprived MCT cells. (B) Dose response curve of apoptosis induced by exposure of serum-deprived cells
to CsA for 72 hours. Mean 6 SD of three independent experiments. *P , 0.05 versus ethanol-treated control.
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